Aktis Oncology Inc.

AKTS | NASDAQ

Price Alert Chart Builder DCF Calculator

$15.93

-$0.92 (-5.46%)

At close: Oct 30, 2026, 4:00 PM ET

$15.93

$0.00 (0.00%)

After-hours: Oct 30, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $856.18M

Enterprise Value $350.1M

Beta 0.45

Average Volume 403.69K

Shares Outstanding (Diluted) 55.32M

Shares Change YoY 5.32%

Institutional Ownership 62.12%

Exchange NASDAQ

ISIN US01021M1045

Price Performance

Price Change 1M -18.2%

Price Change 3M -27.8%

Price Change 6M -18.0%

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) -27.2%

1Y CAGR (ann.) N/A

5Y CAGR (ann.) N/A

All-Time CAGR -34.5%

Valuation

PE Ratio -15.17

Forward PE N/A

PEG Ratio 2.20

Forward PEG 0.16

PS Ratio 85.11

Forward PS 62.60

PB Ratio 1.77

P/FCF Ratio -10.12

P/Adj. FCF Ratio -9.52

P/OCF Ratio -11.71

EV/Sales 34.80

EV/EBIT -4.35

EV/EBITDA -4.50

EV/FCF -4.14

Earnings Yield -6.6%

FCF Yield -9.9%

Adj. FCF Yield -10.5%

Financial Health

Net Cash $515.84M

Total Debt $11.24M

Cash & Short-Term Investments $517.32M

Total Assets $557.6M

Current Ratio 16.33

Quick Ratio 16.33

Debt / Equity Ratio 0.02

Debt / EBITDA -0.14

Debt / FCF -0.13

OCF / Debt -6.70

Interest Coverage 0.00

Altman Z-Score 7.16

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 84.8%

Operating Profit Margin -866.6%

EBITDA Margin -772.8%

Net Profit Margin -727.0%

FCF Margin -840.6%

Adj. FCF Margin -894.3%

SBC / Revenue 53.7%

SBC Impact (per share) -6.4%

Returns

Return on Assets -13.1%

Return on Equity -41.1%

Return on Invested Capital -16.6%

Return on Capital Employed -16.6%

Return on Tangible Assets -13.1%

Historical Growth (CAGR)

Revenue CAGR 3Y 122.1%

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -17.0%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -62.7%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 3

EPS Growth Next 3Y -69.5%

Revenue Growth Next 3Y -7.6%

Earnings Date Nov 12, 2026

EPS Estimate (next Q) -$0.47

EPS Growth Est (next Q) -66.2%

Revenue Est (next Q) $4.02M

Revenue Growth Est (next Q) -12.9%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $37.40

Price Target Upside 134.8%

Cash Flow

Operating Cash Flow $-75.29M

Free Cash Flow $-84.57M

Adj. Free Cash Flow $-89.97M

FCF Per Share -$1.53

OCF Per Share -$1.36

OCF/S Ratio -748.4%

Income Statement

Revenue $10.06M

Gross Profit $8.53M

Operating Income $-87.18M

EBITDA $-77.74M

Net Income $-73.14M

EPS (Diluted) -$1.05

Revenue / Employee $127.34K

Profit / Employee $-925.82K

Employees 79